← Every company
Amylyx Pharmaceuticals Inc Lobbying
What Amylyx Pharmaceuticals Inc discloses spending to lobby Congress, and who it pays to do it. Every lobbying firm files quarterly under the Lobbying Disclosure Act, naming its client, its fee and the issues it worked.
AMLX on carbonthat →Disclosed spend
$80K
across every filing on file
Filings
2
Years covered
1
Firms retained
1
What it lobbies about
Health IssuesMedicare/Medicaid
2 filings
Newest year first, and within a year the largest fee first — a filing period is a word rather than a date, so it cannot order itself.
| Period | Lobbying for them | Disclosed |
|---|---|---|
| 20262nd Quarter (Apr 1 - June 30) | TARPLIN, DOWNS & YOUNG, LLCHealth IssuesMedicare/Medicaid | $40K |
| 20261st Quarter (Jan 1 - Mar 31) | TARPLIN, DOWNS & YOUNG, LLCHealth IssuesMedicare/Medicaid | $40K |
A filing reports either the fee paid to a lobbying firm or what a company spent lobbying for itself, never both, so the total is a sum of the two. The client is named as filed, which is often a subsidiary. Lobbying is lawful, disclosed and extremely common — the figure is context, not an accusation.
More on AMLX
Company overviewEverything on AMLX in one place, with the price.SEC filingsWhat AMLX's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat AMLX's own officers and directors buy and sell.Planned salesSales AMLX insiders have filed notice of.Who owns itEvery manager reporting a position in AMLX.Funds holding itWhich funds and ETFs hold AMLX, and how big a bet.Who lobbies for itThe lobbyists on AMLX's account, and who they worked for.PatentsWhat AMLX is filing at the patent office.